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Background:  
 
Many innovations in palliative care are implemented without 
robust understanding of their effect. Trials are underused as they 
can be considered ethically and pragmatically challenging.  Wait-
list designs show promise as they enable all participants to 








Wait-list trial testing volunteer delivered befriending service  
to those in their last year of life. Local staff are responsible for site 
management and informed consent. Random allocation to receive 
intervention immediately or after a four week wait.  
Data collection at baseline, 4, 8 weeks: WHO QOL BREF, 
Loneliness scale, mMOS-SS, social networks.  
I’d have come out my shell, started getting 
more confidence a bit more, pushing myself 
a little bit more, if I’d had it [befriending 
service] earlier. (Patient, Immediate Trial Arm, 
discussing that they had waited for the intervention 
anyhow irrespective of the trial design) 
Participants: 
 
11 sites  (NHS, hospice & other voluntary sector).  
N=196, baseline response rate 90%). 90 immediate, 86 wait arm. 
60% female, mean age  72 (range 37-92 SD 12), 60% live alone, 93% 
white ethnicity, 47% with cancer 
 
Issues of the wait for the trial: 
• Training & supporting staff to deliver intervention in wait list 
context 
• Training staff in informed consent procedures 
• Expressed disappointment at the wait from local staff 
• Allocating volunteers appropriate to the wait list context 
• Understanding effect and determining length of follow up 
 
I think that for us actually the wait list 
nature of the trial has been unfortunate.  
It’s great that we’ve had so many yeses in 
the last month, but actually I think that we 
could have done some even better work if 
we’d have had just put people on without 
having to, you know … (Befriending service staff) 
There was one client who’d got five weeks 
to live [comment made after death] and 
then we got him on the waiting list so we 
couldn’t do any work with him in those last 
five weeks.  And actually with our client 
group you don’t know when this is going to 
be the last bit. (Befriending service staff)  
Lessons for running wait list trials 
Involving all staff in protocol development to promote ownership 
Determining the appropriate length of wait 
Participants wait for an intervention anyhow – ‘wait’ more 
negatively perceived by staff than participants 
Considerations of managing any delays in the immediate 
intervention arm 
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Conclusions 
Local staff appreciate involvement in rigorously conducted 
research that answers questions important to them 
Wait list trials are feasible and acceptable to staff who believe in 
offering an intervention to participants 
 
I know you’re looking at patients having to 
wait, but, actually, the bigger picture of this 
is, this is going to be phenomenally useful 
to us to make sure that the service is there 
in the future but that we can use as 
evidence for other areas as well (Befriending 
service manager).  
